Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

P O Livingston; G Y Wong; S Adluri; Y Tao; M Padavan; R Parente; C Hanlon; M J Calves; F Helling; G Ritter

doi:10.1200/JCO.1994.12.5.1036

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

Identifier:nobleid.org/w1/20260515/13C604C2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/13C604C2.svg?ark=w1%2F20260515%2F13C604C2)](https://nobleid.org/work/w1/20260515/13C604C2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

Identifier:nobleid.org/w1/20260515/13C604C2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/13C604C2.svg?ark=w1%2F20260515%2F13C604C2)](https://nobleid.org/work/w1/20260515/13C604C2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work